This technology makes it possible to standardise extracts from plants, opening the way for the introduction of a new generation of plant-derived prescription phytomedicines, OTC nutraceuticals and functional foods with health benefits. One of the major objectives of the new company is to commercialize ONP's TQP TM system in Japan. The TQP TM system makes it possible to overcome all current problems associated with extracts from plants, including product definition and variability, by simplifying formulation production and ensuring that the extracts meet the rigorous clinical efficacy and safety standards demanded by the regulatory authorities.
Japan is the one of the largest markets in the world for products made from plant extracts.
This market has grown significantly since 1976 following the reintroduction of botanical-based medicines into Japan's national healthcare system and their designation as being reimbursable products. Applications of the new TQP TM technology will have a large potential in the Japanese market. 2000 Sosei, All rights reserved.